• FAQS
  • ABOUT
  • LOG IN
  • SIGN UP

VBIV Overview

Upcoming Projects (VBIV) Image
  • Don’t see a project related to the company you care about? Create your own!

Expired Projects (VBIV) Image
  • Analyzing VBI Vaccines' Sci-B-Vac Hepatitis B vaccine candidate ahead of the PDUFA date set for November 30, 2021
    Ticker: VBIV
    Execute By: Dec 31, 2021
Upcoming & Overdue Catalysts (VBIV) Image
  • Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (VBIV) Image
  • VBI Vaccines' (VBIV) Sci-B-Vac Hepatitis B vaccine PDUFA date set for November 30, 2021
    Ticker: VBIV
    Occurred on: Dec 01, 2021
  • Phase 1b/2a of VBI Vaccines'(VBIV) BRII-179 (VBI-2601) in Hepatitis B -Boosting of hepatitis B surface antigen antibodies data from the high-dose cohorts expected in 1Q 2021
    Ticker: VBIV
    Occurred on: Jun 23, 2021
  • VBI Vaccines (VBIV) Presents Phase 3 Sci-B-Vac(antigen HBV vaccine) Data at ID Week 2020
    Ticker: VBIV
    Occurred on: Oct 26, 2020
  • VBI Vaccines (VBIV) Announces Dosing of First Recurrent GBM Patient in Phase 2a Study of Cancer Vaccine Candidate, VBI-1901, in Combination with GSK’s AS01B Adjuvant System
    Ticker: VBIV
    Occurred on: Mar 02, 2020
Strategic Initiatives (VBIV) Image
  • GlaxoSmithKline (GSK) and VBI Vaccines (VBIV) Enter Research Collaboration to Evaluate VBIV's LPV Platform
    Tickers: GSK, VBIV
    Announcement Date: Feb 09, 2016
About Us
  • About
  • Pricing
  • Compliance
  • Terms of Use
  • Privacy Policy
Media Center
  • Jobs
Connect with Us
  • facebook Facebook
  • facebook Twitter
  • facebook LinkedIn
  • facebook Email Us
© 2025 Slingshot Insights. All rights reserved.